Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/ki.2013.328PMID 24048377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomics meets the scientific method

  2013cited by this paper
• Plasma metabolomic profiles in different stages of CKD.

  2013cited by this paper
• Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum

  2012cited by this paper
• Metabolomics in the study of kidney diseases

  2012cited by this paper
• Urinary metabolomic analysis for the identification of renal injury in patients with acute heart failure.

  2012cited by this paper
• A Pilot Metabolic Profiling Study in Serum of Patients with Chronic Kidney Disease Based on 1H‐NMR‐Spectroscopy

  2012cited by this paper
• Biomarkers in chronic kidney disease: a review.

  2011cited by this paper
• Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

  2011cited by this paper
• Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

  2011cited by this paper
• Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.

  2010cited by this paper
• Application of proteomic analysis to the study of renal diseases

  2009cited by this paper
• The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.

  2009cited by this paper
• Regulation of glutathione synthesis.

  2009cited by this paper
• Selected reaction monitoring for quantitative proteomics: a tutorial

  2008cited by this paper
• Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage.

  2007cited by this paper
• Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

  2006cited by this paper
• Accumulation of taurine in patients with renal failure.

  2002cited by this paper
• Role of glutamine in human carbohydrate metabolism in kidney and other tissues.

  1999cited by this paper
• Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion

  1991cited by this paper
• Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide.

  1991cited by this paper
• Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients.

  1989cited by this paper
• Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion

  1989cited by this paper

• NMR-based urinary biomarkers in pediatric primary mitochondrial disorders and chronic kidney disease: shared mitochondrial dysfunction, diverging biosignatures

  2026cites this paper
• Jian-Pi-Yi-Shen formula improves kidney function by regulating gut microbiome in rats with chronic kidney disease

  2025cites this paper
• Metabolic profile of urine of albuminuric and non-albuminuric nephropathic diabetic patients suggests TCA-cycle related biomarkers.

  2025cites this paper
• Fecal Microbiome and Urine Metabolome Profiling of Type 2 Diabetes

  2025cites this paper
• A nuclear magnetic resonance spectroscopy metabolomic approach to renal dysfunction in canine leishmaniasis

  2025cites this paper
• Application of volatilomic analysis by electronic nose for the detection of women with preeclampsia at high risk of developing chronic kidney disease.

  2025cites this paper
• Electrolyte and metabolite composition of cystic fluid from a rat model of ARPKD

  2025cites this paper
• Investigating a Systematic and Widespread Misidentification in the Metabolic Profiling Literature: Phenylacetylglutamine and Phenylacetylglycine Signal Misassignment in Proton NMR Spectra of Human and Rodent Urine

  2025cites this paper
• Predictive Immunonutrition for Paediatric Chronic Kidney Disease Surgery: A Multi-omic Data Fusion Framework through Canonical Correlation Analysis

  2025cites this paper
• Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study

  2025cites this paper
• Hyperpolarized 13C NMR Metabolomics of Urine Samples at Natural Abundance Applied to Chronic Kidney Disease.

  2024cites this paper
• Exploring the pharmacological mechanism of fermented Eucommia ulmoides leaf extract in the treatment of cisplatin-induced kidney injury in mice: Integrated traditional pharmacology, metabolomics and network pharmacology.

  2024cites this paper
• Plant Metabolomics: The Future of Anticancer Drug Discovery

  2024cites this paper
• Gut microbiota and renal fibrosis.

  2024cites this paper
• Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy.

  2024cites this paper
• Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.

  2024cites this paper
• Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights

  2024cites this paper
• A new murine undernutrition model based on complementary feeding of undernourished children causes damage to the morphofunctional intestinal epithelium barrier.

  2024cites this paper
• Trimethylamine-N-oxide (TMAO) and predicted risk of cardiovascular events after partial nephrectomy.

  2023cites this paper
• A systematic review of metabolomic findings in adult and pediatric renal disease.

  2023cites this paper
• Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: a systematic review.

  2023cites this paper
• The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development

  2023cites this paper
• Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

  2023cites this paper
• Urinary Metabolite Profile Predicting the Progression of CKD

  2023influential citation
• Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

  2023cites this paper
• Urinary 1H NMR Metabolomic Analysis of Prenatal Maternal Stress Due to a Natural Disaster Reveals Metabolic Risk Factors for Non-Communicable Diseases: The QF2011 Queensland Flood Study

  2023cites this paper
• Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy.

  2023cites this paper
• The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice

  2023cites this paper
• The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease

  2023cites this paper
• Application of metabolomics in urolithiasis: the discovery and usage of succinate

  2023cites this paper
• Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease

  2023cites this paper
• Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics

  2022cites this paper
• Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota

  2022cites this paper
• Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.

  2022cites this paper
• Urine-Based Detection of Biomarkers Indicative of Chronic Kidney Disease in a Patient Cohort from Ghana

  2022cites this paper
• A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cells

  2022cites this paper
• Theranostics A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cells

  2022cites this paper
• TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

  2022cites this paper
• Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study

  2022cites this paper
• Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction

  2022cites this paper
• Opisthorchis viverrini infection induces metabolic disturbances in hamsters fed with high fat/high fructose diets: implications for liver and kidney pathologies.

  2022cites this paper
• In-depth characterisation of the urine metabolome in cats with and without urinary tract diseases

  2022cites this paper
• New Insights from Metabolomics in Pediatric Renal Diseases

  2022cites this paper
• Metabolomics tools for biomarker discovery: applications in chronic kidney disease

  2022cites this paper
• Early prediction of renal graft function: Analysis of a multi-centre, multi-level data set

  2021cites this paper
• Urinary non-targeted toxicokinetics and metabolic fingerprinting of exposure to 3-monochloropropane-1,2-diol and glycidol from refined edible oils.

  2021cites this paper
• Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

  2021cites this paper
• Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis—Identification of Potential Biomarkers in Stable Kidney Transplant Patients

  2021cites this paper
• Urinary Spermidine Predicts and Associates with In-Hospital Acute Kidney Injury after Cardiac Surgery

  2021cites this paper
• Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes

  2021cites this paper
• Metabolomics in Chronic Kidney Diseases: Here to Stay

  2021cites this paper
• Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy

  2021cites this paper
• Combined Untargeted and Targeted Metabolomics Approaches Reveal Urinary Changes of Amino Acids and Energy Metabolism in Canine Babesiosis With Different Levels of Kidney Function

  2021cites this paper
• TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension

  2021cites this paper
• Metabolómica de la nefropatía diabética: tras la huella de indicadores de desarrollo y progresión

  2020cites this paper
• Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators.

  2020cites this paper
• Renal function is associated with plasma trimethylamine-N-oxide, choline, l-carnitine and betaine: a pilot study

  2020cites this paper
• Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations

  2020influential citation
• Chronic kidney disease and kidney stones.

  2020cites this paper
• Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease

  2020cites this paper
• Monitoring of the influence of long-term oxidative stress and ischemia on the condition of kidney using solid phase microextraction chemical biopsy coupled with liquid chromatography high resolution mass spectrometry.

  2020cites this paper
• Differential metabolic profile associated with the condition of normoalbuminuria in the hypertensive population.

  2020cites this paper
• Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease.

  2020cites this paper
• Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis

  2020cites this paper
• SERUM TARGETED HILIC-MS METABOLOMICS-BASED ANALYSIS IN INFANTS WITH URETEROPELVIC JUNCTION OBSTRUCTION.

  2020cites this paper
• Berry fruits modulate kidney dysfunction and urine metabolome in Dahl salt-sensitive rats.

  2020cites this paper
• Berry fruits modulate kidney dysfunction and urine metabolome in Dahl salt-sensitive rats

  2020cites this paper
• Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators

  2020cites this paper
• Analysis of urinary exosomal metabolites identifies cardiovascular risk signatures with added value to urine analysis

  2020cites this paper
• Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan

  2020cites this paper
• Metabolomics of Interstitial Fluid, Plasma and Urine in Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms

  2020cites this paper
• Differential metabolic profile associated with the condition of normoalbuminuria in the hypertensive population

  2020cites this paper
• Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes

  2020cites this paper
• Advances in the Detection, Mechanism and Therapy of Chronic Kidney Disease.

  2019cites this paper
• Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.

  2019cites this paper
• A Novel Metabolic Signature To Predict the Requirement of Dialysis or Renal Transplantation in Patients with Chronic Kidney Disease.

  2019cites this paper
• Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

  2019cites this paper
• Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.

  2019cites this paper
• An update of urine and blood metabolomics in chronic kidney disease.

  2019cites this paper
• Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid

  2019influential citation
• Early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry

  2019cites this paper
• Urinary Biomarkers of Renal Fibrosis.

  2019cites this paper
• Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model

  2019cites this paper
• Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a Diagnostic Panel and Pathogenic Pathways.

  2019cites this paper
• Targeting metabolic dysregulation for fibrosis therapy

  2019cites this paper
• Molecular Model for CKD

  2018cites this paper
• Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis

  2018cites this paper
• Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics

  2018cites this paper
• Biomarkers of obstructive nephropathy using a metabolomics approach in rat.

  2018cites this paper
• Identification of a urine metabolite constellation characteristic for kidney allograft rejection

  2018cites this paper
• Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate

  2018cites this paper
• A review of validated biomarkers obtained through metabolomics

  2018cites this paper
• Metabolite Profiling of Feces and Serum in Hemodialysis Patients and the Effect of Medicinal Charcoal Tablets

  2018cites this paper
• Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS.

  2018cites this paper
• Identification of biomarkers using-omics approach for the early detection of chronic kidney disease and its complications

  2018cites this paper
• Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage

  2018cites this paper
• CKD: Diagnostic and Other Clinical Needs

  2018cites this paper
• Non‐invasive staging of chronic kidney allograft damage using urine metabolomic profiling

  2018cites this paper
• Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

  2017cites this paper
• Metabolomics insights into diabetes nephropathy and protective effects of Radix Scutellariae on rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

  2017cites this paper